Leukemia inhibitory factor (LIF) binding protein attenuates the phlogistic and abolishes the chondral effects of LIF in goat joints

Journal of Rheumatology

Volumn 24, Issue 12, 1997, Pages 2394-2402

  Bell, Michael ^a   Carroll, Graeme J ^a   Chapman, Helen ^e   Layton, Meredith ^c,d   Mills, Jenny ^b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b MURDOCH UNIVERSITY   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^e Royal Perth Rehabilitation Hospital ^*

Author keywords

Arthritis; Cytokine; Goat; Leukemia inhibitory factor binding protein

Indexed keywords

BINDING PROTEIN; KERATAN SULFATE; LEUKEMIA INHIBITORY FACTOR; RECOMBINANT LEUKEMIA INHIBITORY FACTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GOAT; MALE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; WRIST;

ANIMALS; ARTHRITIS; CARTILAGE, ARTICULAR; GOATS; GROWTH INHIBITORS; HUMANS; INJECTIONS, INTRA-ARTICULAR; INTERLEUKIN-6; JOINTS; KERATAN SULFATE; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LEUKOCYTE COUNT; LYMPHOKINES; MALE; PROTEOGLYCANS; RECEPTORS, CYTOKINE; RECEPTORS, OSM-LIF; RECOMBINANT PROTEINS; SWINE; SYNOVIAL FLUID;

EID: 0031452020     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Harris ED Jr: Pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, eds. Textbook of Rheumatology, 3rd ed. Philadelphia: WB Saunders, 1989:905-42.
2. Harris ED: Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
3. Morales TI, Hascall VC: Factors involved in the regulation of proteoglycan metabolism in articular cartilage. Arthritis Rheum 1989;32:1197-201.
4. Nietfeld JJ, Wilbrink B, van der Otter W, Huber J, Huber-Bruning O: Factors involved in the regulation of proteoglycan metabolism in articular cartilage. J Rheumatol 1990;17:818-26.
5. Pettipher ER, Higgs GA, Henderson B: Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 1986;83:8749-53.
6. Van Beuningen HM, Arntz OJ, van den Berg WB: In vivo effects of interleukin-1 on articular cartilage. Arthritis Rheum 1991;34:606-15.
7. Tyler JA: The influence of IL-1 and IGF-1 on the integrity of cartilage matrix. In: Glauert AM, ed. The Control of Tissue Damage. Amsterdam: Elsevier, 1988:197-214.
8. Saklatvala J: Tumour necrosis factor stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322:547-9.
9. Morales TI: Transforming growth factor beta stimulates synthesis of proteoglycan aggregates in calf articular cartilage organ cultures. Arch Biochem Biophys 1991;286:99-106.
10. Tyler JA: Insulin like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem J 1989;260:543-8.
11. Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR: Transforming growth factor beta is a potent inhibitor of interleukin-1 receptor expression: Proposed mechanism for the inhibition of IL-1 action. J Exp Med 1990;172:737-14.
12. Hollander AP, Dieppe PA, Atkins RM, Elson CJ: Hypothesis: Cartilage catabolic cofactors in human arthritis. J Rheumatol 1993;20:223-4.
13. Hilton DJ, Nicola NA, Gough N, Metcalf D: Resolution and purification of three distinct factors produced by Krebs ascites cells which have differentiation and inducing activity on murine myeloid leukaemic cell lines. J Biol Chem 1988;263:9238-43.
14. Anegar I, Moreau JF, Godard A, et al: Production of human interleukin for DA cells/leukemia inhibitory factor by activated monocytes. Cell Immunol 1990;130:50-6.
15. Gearing DP, Gough NM, King JA, et al: Molecular cloning and expression of cDNA encoding a murine leukaemic inhibitory factor. EMBO J 1987;13:3995-4002.
16. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M: Purification of a factor inducing differentiation of mouse myeloid M1 cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem 1984;259:10978-82.
17. Koopman P, Cotton RGH: A factor produced by feeder cells which inhibits embryonal carcinoma cell differentiation: Characterization and partial purification. Exp Cell Res 1984;154:233-42.
18. Smith AG, Hooper ML: Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol 1987;121:1-9.
19. Abe E, Tanaka H, Ishimi Y, et al: Differentiation inducing factor purified from conditioned media of mitogen stimulated spleen cell cultures stimulates bone resorption. Proc Natl Acad Sci USA 1986;83:5958-62.
20. Lotz M, Moats T, Villiger PM: Leukaemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest 1992;90:888-96.
21. Baumann H, Wong GG: Hepatocyte-stimulating factor-III shares structural and functional identity with leukaemia inhibitory factor. J Immunol 1989;143:1163-7.
22. Goddard A, Gasian H, Namlet J, et al: Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood 1988;71:1618-23.
23. Gough NM, Williams RL: The pleiotropic actions of leukaemia inhibitory factor. Cancer Cells 1989;1:77-80.
24. Metcalf D: The leukaemia inhibitory factor. Int J Cell Cloning 1991;9:95-108.
25. Metcalf D, Nicola NA, Gearing DP: Effects of injected leukaemia inhibitory factor on haematopoietic and other tissues in mice blood. Blood 1990;76:50-6.
26. Mori M, Yamaguchi K, Abe K: Identification of a lipoprotein lipase inhibitory protein produced by a melanoma cell line associated with cancer cachexia. Biochem Biophys Res Commun 1989;160:1085-92.
27. Reid IR, Lowe C, Cornish J, et al: Leukaemia inhibitory factor: A novel bone-active cytokine. Endocrinology 1990;126:1416-20.
28. Cornish J, Callon K, King A, Edgar S, Reid IR: The effect of leukaemia inhibitory factor on bone in vivo. Endocrinology 1993;132:1359-66.
29. Carroll GJ, Bell MC: Leukaemia inhibitory factor stimulates proteoglycan resorption in porcine articular cartilage. Rheumatol Int 1993;13:5-8.
30. Bell MC, Carroll GJ: Leukaemia inhibitory factor suppresses proteoglycan synthesis in porcine and caprine cartilage explants. Cytokine 1995;7:137-41.
31. Carroll GJ, Bell MC, Chapman HM, Mills JN, Robinson WF: Leukemia inhibitory factor induces leukocyte infiltration and cartilage proteoglycan degradation in goat joints. J Interferon Cytokine Res 1995;15:567-73.
32. Waring PM, Carroll GJ, Kandiah DA, Buirski G, Metcalf D: Increased levels of leukaemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1993;36:911-5.
33. Kishimoto T, Akira S, Taga T: Interleukin-6 and its receptor: A paradigm for cytokines. Science 1992;258:593-7.
34. Hirano T, Matsuda T, Nakajima K: Signal transduction through gp130 that is shared among the receptors for the interleukin-6 related cytokine subfamily. Stem Cells 1994;12:262-77.
35. Layton MJ, Cross BA, Metcalf D, Ward LD, Simpson RJ, Nicola NA: A major binding protein for leukaemia inhibitory factor in normal mouse serum: Identification as a soluble form of the cellular receptor. Proc Natl Acad Sci USA 1992;89:8616-20.
36. Elliott MJ, Maerc RN, Feldmann M, et al: Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 1993;36:1681-90.
37. Campion GV, Lebsack ME, Lookabaugh J, Gordon G, Catalano M, and the IL-1Ra Arthritis Study Group: Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum1996;37:1092-101.
38. Layton MJ, Lock P, Metcalf D, Nicola NA: Cross species receptor binding characteristics of human and mouse leukemia inhibitory factor suggest a complex binding interaction. J Biol Chem 1994;269:17048-55.
39. Farndale RW, Buttle DJ, Barrett AJ: Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. J Biochem Biophys Acta 1986;883:173-7.
40. Dingle JT, Horsfield P, Fell HB, Barrett MEJ: Breakdown of proteoglycan and collagen induced in pig articular cartilage in organ culture. Ann Rheum Dis 1975;34:303-11.
41. Humbel R, Etringer D: A calorimetric method for the determination of sulphated glycosaminoglycans. Rev Rhum Biochim 1974;11:21-4.
42. Carroll G, McCappin S, Bell M, Schwarzer A, Breidahl P: Comparison of keratan sulphate concentrations and the size distribution of proteoglycans in the synovial fluid of patients with osteoarthritis and pyrophosphate arthropathy. Rheumatol Int 1991;11:63-8.
43. Villiger PM, Geng Y, Lotz M: Induction of cytokine expression by leukaemia inhibitory factor. J Clin Invest 1993;91:1575-81.
44. Villiger P, Terkeltaub, Lotz M: Monocyte chemoattractant protein-1 expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest 1992;90:488-96.
45. Wang Hui, Bell MC, Carroll GJ: Oncostatin M stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage expiants. Cytokine 1996;8:495-500.
46. Schorcemmer HU, Kanzy EJ, Langer KD, Kurrle R: Immunomodulatory activity of recombinant IL-1 receptor on models of experimental rheumatoid arthritis. Agents Actions 1993;39:C113-6.
47. Van Zie KJ, Kohino T, Fischer E, Rock GS, Moldawer KL, Lowry SF: Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor a in vitro and in vivo. Proc Natl Acad Sci USA 1992;89:4845-9.
48. Vincenti MP, Clark TM, Brackerhoff CE: Using inhibitors of metalloproteinases to treat arthritis. Arthritis Rheum 1994;37:1115-26.
49. Buttle DJ, Saklatvala J: Lyposomal cysteine endopeptidases mediate interieukin-1 stimulated cartilage proteoglycan degradation. Biochem J 1992;287:657-61.
50. Campbell IK, Piccola DS, Butler DM, Singleton DK, Hamilton JA: Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue and urokinase-type plasminogen activator. Biochem Biophys Acta 1988;961:183-94.
51. Ilic MZ, Handley CJ, Robinson HC, Mok MT: Mechanism of catabolism of aggrecan by articular cartilage. Arch Biochem Biophys 1992;294:115-22.